Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 2 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Recs

0
Player Avatar chicachick (71.74) Submitted: 6/28/2010 3:40:20 PM : Underperform Start Price: $6.05 NBIX Score: +14.99

ultralong

Featured Broker Partners


Advertisement